CClinicalTrials.gg
Status unknownNCT01592357Updated Mar 19, 2013

The Effects of Tai Chi in Older Patients With Cardiovascular Disease

An interventional study of Tai Chi exercise and Sham Exercise in Cardiovascular Disease, sponsored by McMaster University. Status unknown at 1 site in Canada. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2013-03-19.

Sponsored by McMaster University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Mar 2013), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

Cardiac exercise rehabilitation consists of walking and bicycling activities. As the population requiring rehabilitation is aging, other forms of exercise may be useful and better tolerated. Tai Chi has been used for centuries, is easy to perform even by more debilitated individuals, and promotes improvement in blood pressure, fitness, and relaxation. Tai Chi may be more beneficial for frail cardiac patients because it is especially suited for the unfit and elderly, and can be practiced anywhere. Further studies are required to assess this form of exercise in cardiac patients. The objective of this randomized controlled study is to compare the effects of Tai Chi to "sham exercise" training in 200 frail cardiac patients who have completed six months of cardiac rehabilitation and are 60 years of age or older. Participants will be randomized to Tai Chi or "sham exercise" training and have their gait speed, blood pressure, heart rate, exercise capacity, balance, quality of life and cognitive function assessed before and after 24 week of training.

Read the detailed description

The role of exercise training is well established for cardiac patients to improve fitness and clinical outcomes. Many older cardiac patients even if they initially participate do not maintain regular exercise for a number of reasons. As the population ages there is a need to evaluate other forms of exercise training that may be used alone or in conjunction with standard approaches. Tai Chi is a potentially beneficial exercise for older cardiac patients because it is low-intensity exercise especially suited for unfit and elderly patients. There has been little rigorous evaluation, especially in the cardiac populations, of Tai Chi.

The main objective of this study is to assess the effects of Tai Chi compared to "sham exercise" in cardiac patients that have completed a program of cardiac rehabilitation. The investigators hope to show that six months of Tai Chi training compared to "sham exercise" (with all participants instructed to maintain their standard exercise program), will improve gait speed, exercise capacity, health related quality of life, cognitive function and balance.

This is a single blind randomized controlled trial of 200 cardiac patients, great than or equal to 60 years of age, who have completed six months of cardiac rehabilitation at the Hamilton Health Science Cardiac Health and Rehabilitation Centre. Participants will be randomized to receive either the short and simple 8-forms Tai Chi routine or "sham exercise". The participants in the study will train for a period of six months.

02

Conditions studied

  • Cardiovascular Disease

Keywords

  • cardiac rehabilitation
  • gait speed
  • mind body exercise
  • tai chi
  • cardiac disease
  • frail elderly
03

In context

Cardiovascular Diseases

4,905 studies on the registry are indexed under Cardiovascular Diseases; 919 are open to participants now.

This study's planned enrollment of 200 is above the median of 100 across 2,738 interventional studies indexed under Cardiovascular Diseases.

Browse Cardiovascular Diseases studies →

Lead sponsor

McMaster University is the lead sponsor of 720 studies on the registry; 123 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 2 (33%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Walking Speed \< or = 1.3 m/sec during the gait speed assessment.
  2. Evidence of cardiovascular disease based on a diagnosis of previous myocardial infarction, angiographic findings of coronary artery disease, previous percutaneous coronary intervention, or previous coronary artery bypass graft surgery.
  3. Local resident, with available transportation to the Cardiac Health and Rehabilitation Centre (CHRC) at the Hamilton Health Sciences General Division.
  4. Ability to understand written and verbal instructions and provide written informed consent.
  5. Stable cardiac medical therapy as demonstrated by no change in medication during the 3 months prior to randomization.
  6. Previous completion of the 6 month Cardiac Rehabilitation program (including exercise training component) at the CHRC.

Exclusion criteria

Exclusion Criteria:

  1. New York Heart Association Functional class IV symptoms of shortness of breath or angina.
  2. Development of angina or ST segment depression of > 1 mm during symptom limited exercise testing at \< 80% of predicted maximum power output.
  3. Development of dysrhythmias during exercise (> Lown grade 2).
  4. Resting blood pressure greater than 160 mmHg systolic or 90 mmHg diastolic.
  5. Abnormal blood pressure response to clinical exercise testing (decrease in systolic pressure below resting; decrease of > 20 mmHg in systolic pressure after the normal exercise increase; rise in diastolic blood pressure of > 15 mmHg; maximal systolic blood pressure in excess of 250 mmHg).
  6. Maximum heart rate \< 100 beats per minute in the absence of beta blocker therapy.
  7. Respiratory limitation as assessed by pre-exercise pulmonary function testing (documented restrictive or obstructive lung disease; based on forced expired volume in 1 sec and/or vital capacity measurements \< 70% of predicted).
  8. Major orthopedic disability.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Tai Chi

    Behavioral: Tai Chi exercise

  • Sham comparator
    Sham Exercise

    Behavioral: Sham Exercise

Interventions

  • BehavioralTai Chi exercise

    A short and simple 8-forms Tai Chi routine will be used in this study. This routine has been previously standardized and field tested. Participants will be coached, by a certified Tai Chi instructor, in practicing the proper mechanics of executing each of the eight physical movements comprising the 8-forms of Tai Chi. A brief 5 minute period of walking calisthenics pertinent to Tai Chi movements, postures and diaphragmatic breathing will take place before training to warm up and after training to cool down. The Tai Chi training will be 2 times a week and the total exercise time, including warm-up and cool down, will be 50 minutes for each session. Over a period of 12 weeks, the participants will learn all 8-forms and continue practicing them for the final 12 weeks of the training period.

  • BehavioralSham Exercise

    The sham exercise (control) group will be involved in low-intensity stretching exercises two times per week. These exercises will be designed as a "sham exercise" condition. A brief 5 minute period of walking will take place before the sham exercise to warm up and after the sham exercise to cool down. Sham exercise sessions will include stretching exercises of the neck, trunk and extremities. The total exercise time for the "sham exercise" group will be 50 minutes and participants will meet 2 times per week for a period of 24 weeks.

    Also known as: Control Group

06

What researchers measure

Primary outcomes

  1. Gait speed following 6 months of Tai Chi or sham exercise training

    Gait speed will be measured by having participants walk a 4 metre course at their usual speed. There will be a 1-metre start-up before starting the timing for the walk over 4 metres. Each participant will be timed for 2 walks and the faster of the 2 walks will be used in the analysis.

    Time frame: 24 weeks

Secondary outcomes

  1. Peak exercise oxygen uptake (VO2)

    Peak VO2 will be measured while performing cycle ergometry exercise.

    Time frame: 24 weeks

  2. Resting heart rate

    Resting heart rate will be measured prior to participant performing a cycle ergometry exercise test.

    Time frame: 24 weeks

  3. Blood pressure

    Blood pressure will be measured prior to the participant performing a cycle ergometry exercise test.

    Time frame: 24 weeks

  4. Balance assessment

    Balance will be measured using the functional reach assessment and the single leg stance assessment.

    Time frame: 24 weeks

  5. Health related quality of life (HRQOL)

    The Medical Outcomes Short Form 36 will be used to measure HRQOL.

    Time frame: 24 weeks

  6. Cognitive function following 6 months of Tai Chi or sham exercise training

    Cognitive function will be measured using the Montreal Cognitive Assessment (MoCA) questionnaire (Version 7.1).

    Time frame: 24 weeks

07

Study locations

1 site
  • Cardiac Health & Rehabilitation Centre, Hamilton Health Sciences
    Hamilton, Ontario L8L 2X2, Canada
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 19, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01592357
Lead sponsor
McMaster University
Collaborators
Heart and Stroke Foundation of Ontario, Hamilton Health Sciences Corporation
Responsible party
Robert McKelvie (Professor of Medicine, Division of Cardiology, Medical Director, Heart Failure Program, HHS Medical Director, Cardiac Health and Rehabilitation Program, HHS, McMaster University) — Principal investigator
First posted
May 7, 2012
Start date
Nov 2011
Primary completion
Jun 2013 (estimated)
Completion
Jun 2013 (estimated)
Last update
Mar 19, 2013

Study contacts

Robert S McKelvie, MD, PhD
principal investigator · Hamilton Health Sciences Corporation
Heather M Arthur, PhD
study chair · McMaster University
George Heckman, MD, MSc
study chair · University of Waterloo
Noori Akhtar-Danesh, PhD
study chair · McMaster University
Maureen MacDonald, PhD
study chair · McMaster University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion